Skip to main content
Premium Trial:

Request an Annual Quote

MGH Group to Use OriGene s cDNA Collection

NEW YORK, July 25 (GenomeWeb News) - A research group at Massachusetts General Hospital will use OriGene Technologies' cDNA clone collection for high-throughput functional gene analyses, the Rockville, Md.-based company said today.

 

Under the collaboration, scientist in the laboratory of Brian Seed, a professor of genetics at HarvardMedicalSchooland director of the Center for Computational and Integrative Biology at MGH, will use OriGene's FlagArray full-length cDNAs in expression vectors. The research group will also help OriGene to further develop the platform.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.